本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Viridian Therapeutics, Inc.

21.24
-1.0500-4.71%
盤後21.13-0.1100-0.52%19:54 EDT
成交量:94.41萬
成交額:2,029.48萬
市值:24.06億
市盈率:-6.14
高:22.70
開:22.48
低:21.19
收:22.29
52周最高:34.29
52周最低:13.18
股本:1.13億
流通股本:1.01億
量比:0.71
換手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-3.4579
每股收益(LYR):-3.3245
淨資產收益率:-65.74%
總資產收益率:-30.16%
市淨率:4.27
市盈率(LYR):-6.39

資料載入中...

2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/18

重要事件披露

Form 8-K - Current report
2023/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/09

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/30

重要事件披露

Form 8-K - Current report
2023/09/25

重要事件披露

Form 8-K - Current report
2023/09/12

重要事件披露

Form 8-K - Current report
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]